Evaluation status available after sign-in
About the journal
Current Problems in Cancer: Case Reports is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,210 USD. Declared review time at DOAJ: 22 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-6219
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,210 USD
- Articles in DOAJ
- 400
- Declared review time
- 22 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2021-08-31
- Indexing
- DOAJ
- APC
- 1,210 USD
- Declared review time (DOAJ)
- 22 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
400
Most recent article
last month
Average review time (journal-declared via DOAJ)
22weeks
Works in OpenAlex
414
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
8
i10-index
6
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2021-08-31
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 80%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918231203906676
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Metastasis and carcinoma case studies
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Breast Lesions and Carcinomas
Show all subjects (75)
- Lung Cancer Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Cancer and Skin Lesions
- Cancer and Skin Lesions
- Chemotherapy-related skin toxicity
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Lymphoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Breast Cancer Treatment Studies
- Lymphoma Diagnosis and Treatment
- Cardiac tumors and thrombi
- Cardiac tumors and thrombi
- Viral-associated cancers and disorders
- Colorectal Cancer Treatments and Studies
- Brain Metastases and Treatment
- Colorectal Cancer Treatments and Studies
- Breast Cancer Treatment Studies
- Cardiac tumors and thrombi
- Breast Cancer Treatment Studies
- Brain Metastases and Treatment
- HER2/EGFR in Cancer Research
- Renal cell carcinoma treatment
- HER2/EGFR in Cancer Research
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Cancer Genomics and Diagnostics
- Advanced Breast Cancer Therapies
- Vascular Tumors and Angiosarcomas
- Vascular Tumors and Angiosarcomas
- Colorectal and Anal Carcinomas
- Neuroendocrine Tumor Research Advances
- Cancer Treatment and Pharmacology
- Breast Lesions and Carcinomas
- Colorectal and Anal Carcinomas
- Advanced Breast Cancer Therapies
- Cancer Treatment and Pharmacology
- Breast Lesions and Carcinomas
- Urinary and Genital Oncology Studies
- Viral-associated cancers and disorders
- Testicular diseases and treatments
- Viral-associated cancers and disorders
- Chemotherapy-related skin toxicity
- Male Breast Health Studies
- Chemotherapy-related skin toxicity
- Testicular diseases and treatments
- Lung Cancer Research Studies
- Autoimmune Neurological Disorders and Treatments
- Multiple Myeloma Research and Treatments
- CNS Lymphoma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Nonmelanoma Skin Cancer Studies
- Endometrial and Cervical Cancer Treatments
- CNS Lymphoma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Ovarian cancer diagnosis and treatment
- Glioma Diagnosis and Treatment
Keywords (DOAJ)
- cancer case reports
- clinical oncology
- cancer diagnosis and treatment
- tumor biology
- cancer management
- multidisciplinary oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ